-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on WAVE Life Sciences, Lowers Price Target to $23

Benzinga·08/04/2026 18:13:22
Listen to the news
Mizuho analyst Salim Syed maintains WAVE Life Sciences (NASDAQ:WVE) with a Outperform and lowers the price target from $27 to $23.